Eperisone


Concise Prescribing Info
Indications/Uses
Muscle spasms.
Dosage/Direction for Use
Adult : PO 50 mg tid, adjust dose based on age and symptoms.
Dosage Details
Oral
Muscle spasms
Adult: 50 mg tid, adjust dose based on age and symptoms.
Administration
Should be taken with food.
Contraindications
Lactation.
Special Precautions
Hepatic impairment. Pregnancy.
Adverse Reactions
Significant: Shock, anaphylaxis reactions (e.g. redness, itching, urticaria, oedema, dypnoea), Stevens-Johnson syndrome and toxic epidermal necrolysis.
Blood and lymphatic system disorders: Anaemia.
Cardiac disorders: Palpitations.
Gastrointestinal disorders: Nausea, vomiting, stomach discomfort, abdominal pain, diarrhoea, constipation, stomatitis, feeling of enlarged abdomen, hiccup.
General disorders and admin site conditions: Weakness, fatigue, diaphoresis.
Investigations: Elevated BUN.
Metabolism and nutrition disorders: Anorexia, thirst.
Musculoskeletal and connective tissue disorders: Stiffness, muscle hypotonia.
Nervous system disorders: Headache, numbness of extremities, tremor, light-headedness, dizziness.
Psychiatric disorders: Sleepiness, insomnia.
Renal and urinary disorders: Proteinuria, urinary retention, urinary incontinence.
Skin and subcutaneous tissue disorders: Rash, pruritus, erythema exudative multiforme.
Vascular disorders: Hot flushes.
Patient Counseling Information
This drug may cause weakness, light-headedness or sleepiness, if affected, do not drive or operate machinery.
Drug Interactions
Concomitant use of methocarbamol with tolperizone HCl may cause visual accommodation disturbance.
Action
Description: Eperisone is centrally-acting agent which relaxes skeletal muscles by inhibition of experimentally-induced muscle rigidity, suppression of spinal reflexes and reduction of muscle spindle sensitivity via γ-motor neurons. It also dilates vascular smooth muscles and augments blood flow.
Pharmacokinetics:
Absorption: Time to peak plasma concentration: 1.6-1.9 hours.
Distribution: Enters breast milk.
Excretion: Half-life elimination: 1.6-1.8 hours.
Chemical Structure

Chemical Structure Image
Eperisone

Source: National Center for Biotechnology Information. PubChem Database. Eperisone, CID=3236, https://pubchem.ncbi.nlm.nih.gov/compound/Eperisone (accessed on Jan. 22, 2020)

Storage
Store below 30°C.
MIMS Class
ATC Classification
M03BX09 - eperisone ; Belongs to the class of other centrally-acting muscle relaxants.
References
Buckingham R (ed). Eperisone. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 31/01/2019.

Disclaimer: This information is independently developed by MIMS based on Eperisone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
  • Myonal
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in